Galmed Pharmaceuticals Stock (NASDAQ: GLMD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.502K / 210.584K |
Day Range | - - - |
52 Wk Range | 0.260 - 7.800 |
Market Cap | $2.194M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 0.68% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Galmed Pharmaceuticals (NASDAQ: GLMD) through any online brokerage.
There are no as such competitors for Galmed Pharmaceuticals.
The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Maxim Group on Monday, July 24, 2023. The analyst firm set a price target for 4.00 expecting GLMD to rise to within 12 months (a possible 995.89% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $0.365 last updated Today at April 19, 2024 at 7:14 AM EDT.
There are no upcoming dividends for Galmed Pharmaceuticals.
Galmed Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 30, 2024.
There is no upcoming split for Galmed Pharmaceuticals.
Galmed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.